The HFSA Heart Failure Seminar: Focus on Hypertrophic Cardiomyopathy (HCM) is part of the educational seminar series, featuring a multidisciplinary panel of experts presenting a case-based program that is designed to provide the most current information on the genetics, pathophysiology, diagnosis, clinical trial data, and optimal use of current and emerging treatment options for the management of patients with HCM.
This activity is intended for cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
At the conclusion of this activity, learners will be better able to:
- Review the genetics, pathophysiology, and diagnosis of hypertrophic cardiomyopathy.
- Discuss the clinical trial data and optimal use of current and emerging treatment options for the management of patients with hypertrophic cardiomyopathy.
- Identify advanced treatment options for the management of challenging patients with hypertrophic cardiomyopathy.
Program Agenda
All sessions are listed in Eastern Standard Time.
Welcome Remarks and Introduction
Carolyn Y. Ho, MD
Remembering the Basics: Diagnosis, Pathophysiology and Genetics (Including the Family)
Sharlene Day, MD
Management the Usual Approach
Carolyn Y. Ho, MD
New Kids on the Block: New Medications and Future Approaches
Victoria Parikh, MD
Q&A
All Faculty
What Happens When the Usual is Not Enough: Referral and Advanced Therapy
Lynne Warner Stevenson, MD, FHFSA
Case Presentation: Mild LV Systolic Dysfunction
Michael Ayers, MD
Moderated Discussion
All Faculty
Closing Remarks